iShares MSCI Malaysia ETF vs Indivior Pharmaceuticals Inc. Common Stock — how do they compare? iShares MSCI Malaysia ETF trades at $26.86 (market cap $241.37M), while Indivior Pharmaceuticals Inc. Common Stock trades at $34.01 (market cap $4.18B). The key difference: Indivior Pharmaceuticals Inc. Common Stock is far larger — about 17.3× iShares MSCI Malaysia ETF's market cap, and Indivior Pharmaceuticals Inc. Common Stock is trading nearer its 52-week high, iShares MSCI Malaysia ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares MSCI Malaysia ETF for 68 Days and Indivior Pharmaceuticals Inc. Common Stock for 0 Days on average.
| EWM | INDV | |
|---|---|---|
Market Cap | $241.37M | $4.18B |
Volume | 74,129 | 1,819,746 |
Sector | Broad Market / Factor | Health |
52-Week High | $30.42 | $41.83 |
52-Week Low | $25.47 | $24.09 |
Typical Hold Time | 68 Days | 0 Days |
Enterprise Value | — | $4.47B |
Signals from Pluang's Aura AI — not financial advice
EWM trades at $26.96, up 0.63% today, but technical indicators signal a bearish trend with moving averages and ADX suggesting selling pressure. Key financial ratios like P/E and P/S are unavailable, limiting fundamental clarity. Recent news highlights external risks, such as regional haze-related disruptions affecting operations in Malaysia, which could impact investor confidence.
The outlook remains cautious due to weak technicals and limited fundamental data. Risks include environmental disruptions and market volatility. Investment opportunities hinge on upcoming financial disclosures to validate growth prospects, while current sentiment leans bearish amid uncertainty.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
EWM tracks the MSCI Malaysia Index, providing exposure to the Malaysian equity market. It offers a diversified portfolio of large and mid-sized companies across various sectors in Malaysia.
Read more on EWM →Indivior Pharmaceuticals, Inc. is a pharmaceutical company focused on treatments for opioid use disorder and other addiction-related conditions, including its Suboxone film and tablet products.
Read more on INDV →